Open AccessPulmonary toxicity following bleomycin use: A single-center experience
Author(s) -
Irappa Madabhavi,
Gaurang Modi,
Apurva Patel,
Asha Anand,
Harsha Panchal,
Sonia Parikh
Publication year - 2017
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.204887
Subject(s) - medicine , bleomycin , pulmonary toxicity , interstitial lung disease , dlco , asymptomatic , etoposide , bronchiectasis , dacarbazine , abvd , lung cancer , vinblastine , surgery , lung , vincristine , chemotherapy , diffusing capacity , cyclophosphamide , lung function
Bleomycin-induced pulmonary (BIP) toxicity is a notorious entity and cropped up in roughly 10% of cases. The aim of the study is to evaluate BIP at our tertiary care cancer center.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom